Centrifuges Increase Capacity and Flexibility - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Centrifuges Increase Capacity and Flexibility


Pharmaceutical Technology
Volume 37, Issue 6, pp. 2

Thermo Scientific’s general purpose centrifuges feature increased capacity and flexibility with rotor improvements including the Thermo Scientific TX-1000 rotor, which employs a 4-liter capacity in a traditional 3-liter footprint. Additionally, the MicroClick 30 x 2 rotor offers a 30-place capacity for microtube and nucleic acid spin columns, and is used for molecular biology applications. According to the company, these high-capacity rotors are designed to process more tubes in fewer runs, saving time while reducing wear on the centrifuge. The general purpose centrifuge floor models conserve bench space with a 25% smaller footprint compared to refrigerated benchtop models and a working height of 79 cm, providing ergonomic design for removing tubes and exchanging rotors.

Thermo Scientific

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
33%
Breakthrough designations
11%
Protecting the supply chain
39%
Expedited reviews of drug submissions
11%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here